SCHEMBL2494425

SCHEMBL2494425

C1=Cc2c3ccc(c2C1)CC3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8661024 0.65 ALDH1A1 (0.31)
SCHEMBL1477929 0.60 CES2 (0.30)
SCHEMBL1826218 0.60 CYP1A2 (0.32)
SCHEMBL19996797 0.59
SCHEMBL302728 0.59
SCHEMBL6662462 0.56
Hydrochloric Acid SCHEMBL7039938 0.56
SCHEMBL18774732 0.56
SCHEMBL14959006 0.55
SCHEMBL23944932 0.54 PARP1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690528-B2 Breath analysis system and methods for asthma, tuberculosis and lung cancer diagnostics and disease management TricornTech Taiwan (TW) 2023-07-04 US disclosed
US-20200178842-A1 BREATH ANALYSIS SYSTEM AND METHODS FOR ASTHMA, TUBERCULOSIS AND LUNG CANCER DIAGNOSTICS AND DISEASE MANAGEMENT TRICORNTECH CORPORATION (TW) 2020-06-11 US disclosed
US-10568541-B2 Breath analysis systems and methods for asthma, tuberculosis and lung cancer diagnostics and disease management TricornTech Taiwan (TW) 2020-02-25 US disclosed
EP-2369989-A1 BREATH ANALYSIS SYSTEMS AND METHODS FOR ASTHMA, TUBERCULOSIS AND LUNG CANCER DIAGNOSTICS AND DISEASE MANAGEMENT Tricorntech Corporation (US) 2011-10-05 EP disclosed
WO-2010065452-A1 BREATH ANALYSIS SYSTEMS AND METHODS FOR ASTHMA, TUBERCULOSIS AND LUNG CANCER DIAGNOSTICS AND DISEASE MANAGEMENT TRICORNTECH CORPORATION (US) 2010-06-10 WO disclosed
US-20100137733-A1 BREATH ANALYSIS SYSTEMS AND METHODS FOR ASTHMA, TUBERCULOSIS AND LUNG CANCER DIAGNOSTICS AND DISEASE MANAGEMENT TRICORN TECH CORPORATION (US) 2010-06-03 US disclosed